Forbes has published a feature on cultivate(MD) portfolio company Prana Surgical and its FDA-cleared Prana System, a single-use electrosurgical device that combines CT-guided localization and tissue excision in one instrument. The article, written by Forbes contributor Geri Stengel, makes the case that lung cancer has become a women’s health issue that the funding and awareness […]
Prana Surgical Featured in Forbes Read More »
cultivate(MD) portfolio company Capitan Orthopedics, Inc. announced that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacer™ implant. “I am excited to announce that Capitan Orthopedics, Inc. has received Breakthrough Device Designation for its SupraSpacer™ implant technology. This is yet another milestone achievement for our team
cultivate(MD) portfolio company Shoulder Innovations, Inc., (NYSE: SI) announced full commercial launch of the InSet® I-135RFX Humeral Stem. The commencement of full launch follows a successful limited market release and receipt of additional FDA 510(k) clearance for an expanded set of fracture indications, enabling the InSet™ I-135RFX to now be utilized in all primary, revision,
cultivate(MD) portfolio company Strados Labs, the respiratory endpoint intelligence company, announced the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados’ suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) — complementing its existing technologies for cough monitoring and
Strados Labs Acquires Clinical Trial Business of NuvoAir Read More »
Nanochon, a cultivate(MD) portfolio company developing an implant for treating articular cartilage defects in the knee, has secured commitments to close an oversubscribed funding round, bringing its total capital raised to date to $11.3 million. The round was led by cultivate (MD), with significant contributions from The University of Virginia UVA Seed Fund, WSGR, Wealthing
Nanochon closes $4.1M Seed Prime II Funding Round Read More »
First-in-human procedures mark a critical milestone supporting the system’s clinical development Prana Surgical, a cultivate(MD) portfolio company, announced the completion of the first five clinical procedures using the Prana System™ as part of its early feasibility study in Australia. The Prana System™ has been developed to enable image-guided, minimally invasive surgery, conserving healthy tissue and
